The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

SINCE the 1980s, researchers have worked tirelessly to develop effective treatments that can suppress the HIV virus to undetectable levels. As a result, by taking a single daily dose of an ...

Long-term HIV/AIDS survivors in San Francisco have drafted a statement of principles demanding greater inclusion in policy making. The San Francisco Principles will be announced at an in-person news ...

A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes ...

In 1983, AIDS hysteria was sweeping the country. This is the story of how a Denver conference empowered a generation—and helped shape a new era of advocacy. A group of marchers carry a “Fighting For ...

South Africa 's health minister on Tuesday called lenacapavir, the first twice-yearly HIV prevention jab in the world, a ...

HIV has been in retreat around the world. But with cuts to foreign aid, it's less clear where the trend lines go from here. NPR's Ari Shapiro talks to author Emily Bass about the future of the virus.

The UK's drugs cost-effectiveness watchdog has given a positive recommendation for ViiV Healthcare's HIV drug, enabling ...

In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and ...